Stay updated on Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial

Sign up to get notified when there's something new on the Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Melanoma and related topics (MedlinePlus Genetics) were added, and revision updated to v3.5.0 (removing v3.4.3).
    Difference
    0.2%
    Check dated 2026-03-19T05:21:25.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.3. Related topics such as Melanoma and MedlinePlus Genetics were removed, and Revision: v3.4.2 was deleted.
    Difference
    0.2%
    Check dated 2026-03-12T02:27:17.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Added related topics: Melanoma and MedlinePlus Genetics to the Related Topics section; no deletions observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-18T16:33:54.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is shown as the system revision label, and the government funding operating-status notice has been removed. There are no changes to trial content, eligibility criteria, locations, or study outcomes.
    Difference
    0.4%
    Check dated 2026-02-11T11:55:23.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Added a funding/status notice and a version revision (v3.4.1). Removed Melanoma and related topics (MedlinePlus Genetics) from the page.
    Difference
    0.6%
    Check dated 2026-02-04T06:26:07.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    The page now displays a glossary option and adds new metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). It also removes the older labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4).
    Difference
    0.2%
    Check dated 2026-01-28T04:29:10.000Z thumbnail image

Stay in the know with updates to Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial page.